Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Hidetoshi Ikeoka"'
Autor:
Vanessa Taieb, Hidetoshi Ikeoka, Fang-Fang Ma, Katarzyna Borkowska, Samuel Aballea, Keiko Tone, Nobuo Hirotsu
Publikováno v:
Терапевтический архив, Vol 92, Iss 11, Pp 122-131 (2020)
Aim. Baloxavir marboxil (baloxavir) is the first cap-dependent endonuclease inhibitor being studied for the treatment of influenza in single oral dosing regimen. This network meta-analysis (NMA) evaluated the efficacy and safety of baloxavir compared
Externí odkaz:
https://doaj.org/article/c3fbf548203e465baa7d80afee4ebbf0
Autor:
Kenji Kurazono, Hidetoshi Ikeoka, Shinzo Hiroi, Kosuke Iwasaki, Tomomi Takeshima, Daisuke Tamura
Publikováno v:
Advances in Therapy. 39:1724-1742
Certain drug characteristics, including dosage and form, are associated with either convenience or inconvenience for the patients taking them, and any inconvenience can be considered as a "cost" in disease treatment. Multiple antivirals are available
Autor:
Hidetoshi Ikeoka, Manabu Akazawa, Shinzo Hiroi, Tomomi Takeshima, Kosuke Iwasaki, Kenji Kurazono
Aims To estimate the cost of antiviral medication guidance and/or support from the perspective of healthcare professionals by administration route (oral or inhalant). Methods An online survey (December 2020) was conducted among physicians, pharmacist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33996a4c3265fef1f0aa3752165639a9
Autor:
Kosuke Iwasaki, Hiroshi Mukae, Tomomi Takeshima, Naoki Hosogaya, Takahiro Takazono, Shinzo Hiroi, Akira Yokomasu, Hidetoshi Ikeoka
Aims: Estimating the monetary value of the convenience of using influenza antivirals approved in Japan from a patient perspective using a conjoint analysis. Methods: An online survey (August 2020) was performed on individuals aged 20–64 years livin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c954be42a77145ab491f4a7697c45cf9
Autor:
Naoki Hosogaya, Takahiro Takazono, Akira Yokomasu, Shinzo Hiroi, Hidetoshi Ikeoka, Kosuke Iwasaki, Tomomi Takeshima, Hiroshi Mukae
Publikováno v:
Journal of Medical Economics; Nov2021, Vol. 24, p244-254, 11p
Publikováno v:
Progress in Modern Biomedicine. 2021, Vol. 21 Issue 4, p683-682. 6p.
Publikováno v:
Progress in Modern Biomedicine. 2021, Vol. 21 Issue 4, p678-682. 5p.
Autor:
Hosogaya, Naoki, Takazono, Takahiro, Kurazono, Kenji, Hiroi, Shinzo, Iwasaki, Kosuke, Takeshima, Tomomi, Ha, Chise, Mukae, Hiroshi
Publikováno v:
Advances in Therapy; Aug2023, Vol. 40 Issue 8, p3525-3542, 18p
Autor:
Morita, Ippei, Kurazono, Kenji, Yoshida, Manami, Hiroi, Shinzo, Iwasaki, Kosuke, Takeshima, Tomomi, Ha, Chise, Igarashi, Ataru
Publikováno v:
Journal of Medical Economics; Jan-Dec2023, Vol. 26 Issue 1, p793-801, 9p
Autor:
Kurazono, Kenji, Ikeoka, Hidetoshi, Hiroi, Shinzo, Iwasaki, Kosuke, Takeshima, Tomomi, Tamura, Daisuke
Publikováno v:
Advances in Therapy; Apr2022, Vol. 39 Issue 4, p1724-1742, 19p